Information  X 
Enter a valid email address

EKF Diagnostics Hldg (EKF)

  Print      Mail a friend

Thursday 27 September, 2018

EKF Diagnostics Hldg

Notice of GM

RNS Number : 1595C
EKF Diagnostics Holdings PLC
27 September 2018

EKF Diagnostics Holdings plc

("EKF", the "Company")


Notice of General Meeting


EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed medical diagnostics business, announces that a general meeting of the Company will be held at the offices of Harwood Capital LLP, 6 Stratton Street, Mayfair, London W1J 8LD at 11 a.m. on 19 October 2018 (the "General Meeting") for the purpose of considering and, if thought fit, approving a resolution to approve a distribution of the Company's shareholding in Renalytix AI plc to the Company's shareholders.


A copy of the circular containing the notice convening the General Meeting will be available today on the Company's website,, in accordance with AIM Rule 20 and the Company's articles of association, and it will also be posted to shareholders along with a form of proxy shortly.



EKF Diagnostics Holdings plc

Christopher Mills, Non-Executive Chairman

Tel: 029 2071 0570

Julian Baines, CEO 

Richard Evans, FD & COO


N+1 Singer (Nomad & Broker)

Tel: 020 7496 3000

Aubrey Powell / Lauren Kettle / George Tzimas

Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t